[96a5a0]: / output / allTrials / identified / NCT00838201_identified.json

Download this file

195 lines (195 with data), 8.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
{
"info": {
"nct_id": "NCT00838201",
"official_title": "An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab (AMG 162) in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-Metastatic Prostate Cancer",
"inclusion_criteria": "* Subjects must be currently participating in the 20040138 Amgen study\n* Subjects must sign the informed consent before any study specific procedures are performed.\n\nExclusion Criteria\n\n* Subjects with any prior diagnosis of bone metastasis\n* Known hypocalcemia\n* Developed sensitivity to mammalian cell derived drug products during the 20040138 study\n* Currently receiving any investigational product other than denosumab or having received any investigational product during the 20040138 study\n* Any disorder that, in the opinion of the investigator, may compromise the ability of the subject to give written informed consent and/or comply with study procedures\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Subjects must be currently participating in the 20040138 Amgen study",
"criterions": [
{
"exact_snippets": "Subjects must be currently participating in the 20040138 Amgen study",
"criterion": "participation in the 20040138 Amgen study",
"requirements": [
{
"requirement_type": "status",
"expected_value": "currently participating"
}
]
}
]
},
{
"line": "* Subjects must sign the informed consent before any study specific procedures are performed.",
"criterions": [
{
"exact_snippets": "Subjects must sign the informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "* Subjects with any prior diagnosis of bone metastasis",
"criterions": [
{
"exact_snippets": "any prior diagnosis of bone metastasis",
"criterion": "bone metastasis",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
}
]
},
{
"line": "* Known hypocalcemia",
"criterions": [
{
"exact_snippets": "Known hypocalcemia",
"criterion": "hypocalcemia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Developed sensitivity to mammalian cell derived drug products during the 20040138 study",
"criterions": [
{
"exact_snippets": "Developed sensitivity to mammalian cell derived drug products",
"criterion": "sensitivity to mammalian cell derived drug products",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Currently receiving any investigational product other than denosumab or having received any investigational product during the 20040138 study",
"criterions": [
{
"exact_snippets": "Currently receiving any investigational product other than denosumab",
"criterion": "investigational product",
"requirements": [
{
"requirement_type": "current use",
"expected_value": false
}
]
},
{
"exact_snippets": "having received any investigational product during the 20040138 study",
"criterion": "investigational product",
"requirements": [
{
"requirement_type": "past use during 20040138 study",
"expected_value": false
}
]
}
]
},
{
"line": "* Any disorder that, in the opinion of the investigator, may compromise the ability of the subject to give written informed consent and/or comply with study procedures",
"criterions": [
{
"exact_snippets": "Any disorder that, in the opinion of the investigator, may compromise the ability of the subject to give written informed consent",
"criterion": "disorder affecting ability to give informed consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Any disorder that, in the opinion of the investigator, may ... comply with study procedures",
"criterion": "disorder affecting ability to comply with study procedures",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "Must be MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "Exclusion Criteria",
"criterions": []
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}